Neoleukin Therapeutics

YTD

ALL

Why Robinhood?

You can watch NLTX and buy or sell other stocks, ETFs, and their options commission-free!

About NLTX

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.

CEO

Rachel L. McMinn, PhD

CEORachel L. McMinn, PhD

Employees

107

Employees107

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2018

Founded2018

Employees

107

Employees107

NLTX Key Statistics

Market cap

449.23M

Market cap449.23M

Price-Earnings ratio

-3.85

Price-Earnings ratio-3.85

Dividend yield

—

Dividend yield—

Average volume

281.85K

Average volume281.85K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$74.49

52 Week high$74.49

52 Week low

$6.88

52 Week low$6.88

People also own

Based on the portfolios of people who own NLTX. This list is generated using Robinhood data, and it’s not a recommendation.